GGrantIndex
← Leaderboards

J. Edward Puzas

University Of Rochester

$3,115,946
Attributed
$3,115,946
Total exposure
8
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.7M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,315,669 · 9

By mechanism

P01$5,199,723 · 3
P30$1,466,433 · 2
P50$1,189,620 · 1
R13$242,939 · 2
R01$216,954 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Programs

Research focus

ProgramsResearch PersonnelScienceFacultyScientistMusculoskeletalInterestSiteOsteoporosisSkillsGrantResearch Project GrantsCareerAwardFundingLearningWritingMentorsInternationalSymposiumUnited States National Institutes Of HealthBiomedical ResearchBasic ScienceLectures

Grant awards (29)

USBJI Young Investigators Initiative Career Mentoring Program.$50,070
R13 · FY2025 · AR · contact PI
USBJI Young Investigator Initiative Career Mentoring Program$36,898
R13 · FY2023 · AR · contact PI
USBJI Young Investigator Initiative Career Mentoring Program$36,898
R13 · FY2022 · AR · contact PI
USBJI Young Investigator Initiative Career Mentoring Program$36,898
R13 · FY2021 · AR · contact PI
USBJI Young Investigators Initiative Career Mentoring Program$15,000
R13 · FY2020 · AR · contact PI
USBJI Young Investigators Initiative Career Mentoring Program$15,000
R13 · FY2019 · AR · contact PI
USBJI Young Investigators Initiative Career Mentoring Program$15,000
R13 · FY2018 · AR · contact PI
Tissue Engineering and Therapeutic Advances in Musculoskeletal Medicine$271,666
P30 · FY2010 · AR · contact PI
P3: Role of PTH in enhancing fracture repair in aging (Clinical Trial)$211,046
P50 · FY2010 · AR · contact PI
Tissue Engineering and Therapeutic Advances in Musculoskeletal Medicine$376,014
P30 · FY2009 · AR · contact PI
P3: Role of PTH in enhancing fracture repair in aging (Clinical Trial)$277,542
P50 · FY2009 · AR · contact PI
P3: Role of PTH in enhancing fracture repair in aging (Clinical Trial)$240,877
P50 · FY2008 · AR · contact PI
1st Advances in Rare Bone Diseases Conference$37,175
R13 · FY2008 · AR · contact PI
P3: Role of PTH in enhancing fracture repair in aging (Clinical Trial)$263,335
P50 · FY2007 · AR · contact PI
Lead Toxicity in the Skeleton & Its Role in Osteoporosis$191,137
P01 · FY2007 · ES · contact PI
P3: Role of PTH in enhancing fracture repair in aging (Clinical Trial)$196,820
P50 · FY2006 · AR · contact PI
Lead Toxicity in the Skeleton &Its Role in Osteoporosis$1,727,163
P01 · FY2005 · ES
Lead Toxicity in the Skeleton &Its Role in Osteoporosis$972,788
P01 · FY2004 · ES
Lead Toxicity in the Skeleton &Its Role in Osteoporosis$434,396
P01 · FY2004 · ES
Lead Toxicity in the Skeleton &Its Role in Osteoporosis$960,057
P01 · FY2003 · ES
Lead Toxicity in the Skeleton &Its Role in Osteoporosis$914,182
P01 · FY2002 · ES
Core--Osteotoxicology$228,547
P30 · FY2002 · ES
Histopathology Core$0
P01 · FY2002 · ES
Molecular Mechanism of Lead's Effect on Osteoc$0
P01 · FY2002 · ES
Core--Osteotoxicology$228,547
P30 · FY2001 · ES
Core--Osteotoxicology$120,553
P30 · FY2001 · ES
LEAD EFFECT ON SKELETAL REMODELING IN VITRO$216,954
R01 · FY2000 · ES
Core--Osteotoxicology$120,553
P30 · FY2000 · ES
Core--Osteotoxicology$120,553
P30 · FY2000 · ES